Indoco Remedies is currently trading at Rs. 68.45, up by 0.50 points or 0.74% from its previous closing of Rs. 67.95 on the BSE.
The scrip opened at Rs. 68.00 and has touched a high and low of Rs. 68.70 and Rs. 67.60 respectively.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 83.00 on 04-Sep-2012 and a 52 week low of Rs. 50.35 on 22-Mar-2012.
Last one week high and low of the scrip stood at Rs. 73.50 and Rs. 67.00 respectively. The current market cap of the company is Rs. 630.00crore.
The promoters holding in the company stood at 59.19% while Institutions and Non-Institutions held 16.12% and 24.69% respectively.
Indoco Remedies has acquired a 60.04% stake in Indoco Industrial Designers & Engineers for a consideration of Rs. 22.52 Lacs. This company is engaged in the business of providing turn key solutions to Pharmaceutical Companies for building their plants.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1688.75 |
Dr. Reddys Lab | 1108.55 |
Cipla | 1433.45 |
Lupin | 1982.65 |
Zydus Lifesciences | 859.55 |
View more.. |